L
Lirong Liang
Researcher at Capital Medical University
Publications - 49
Citations - 2079
Lirong Liang is an academic researcher from Capital Medical University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 16, co-authored 25 publications receiving 1325 citations. Previous affiliations of Lirong Liang include Beijing Chao-Yang Hospital.
Papers
More filters
Journal ArticleDOI
Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study.
Chen Wang,Jianying Xu,Lan Yang,Yong-jian Xu,Xiangyan Zhang,Chunxue Bai,Jian Kang,Pixin Ran,Huahao Shen,Fuqiang Wen,Kewu Huang,Wanzhen Yao,Tie-ying Sun,Guangliang Shan,Ting Yang,Ting Yang,Yingxiang Lin,Sinan Wu,Jianguo Zhu,Ruiying Wang,Zhihong Shi,Jianping Zhao,Xianwei Ye,Yuanlin Song,Qiuyue Wang,Yumin Zhou,Liren Ding,Yahong Chen,Yanfei Guo,Fei Xiao,Yong Lu,Xiaoxia Peng,Biao Zhang,Dan Xiao,Chung-Shiuan Chen,Zuomin Wang,Hong Zhang,Xiaoning Bu,Xiaolei Zhang,Xiaolei Zhang,Li An,Shu Zhang,Zhixin Cao,Qingyuan Zhan,Qingyuan Zhan,Yuanhua Yang,Bin Cao,Bin Cao,Huaping Dai,Huaping Dai,Lirong Liang,Jiang He +51 more
TL;DR: Prevalence of spirometry-defined COPD is highly prevalent in the Chinese adult population and prevention and early detection of COPD using spirometry should be a public health priority in China to reduce COPD-related morbidity and mortality.
Journal ArticleDOI
Prevalence, risk factors, and management of asthma in China: a national cross-sectional study
Kewu Huang,Ting Yang,Jianying Xu,Lan Yang,Jianping Zhao,X. Y. Zhang,Chunxue Bai,Jian Kang,Pixin Ran,Huahao Shen,Fuqiang Wen,Yu-Hong Chen,Tieying Sun,Guangliang Shan,Yingxiang Lin,G Xu,Sinan Wu,Chaolong Wang,Rongkun Wang,Zhihong Shi,Yang Xu,Xianwei Ye,Yuanlin Song,Qiuyue Wang,Yumin Zhou,Wen Li,Liren Ding,C Wan,Wanzhen Yao,Yanfei Guo,Fei Xiao,Yong Lu,Xiaoxia Peng,Boli Zhang,Dan Xiao,Zuomin Wang,Zhengming Chen,Xiaoning Bu,Hong Zhang,Li An,Shu Zhang,Jiang Zhu,Zhixin Cao,Qingyuan Zhan,Yuanhua Yang,Lirong Liang,Xin Tong,Huaping Dai,Bin Cao,Tangchun Wu,Kian Fan Chung,Jiang He,Jiang He +52 more
TL;DR: The national prevalence of asthma in a representative sample of the Chinese population was 4·2% (95% CI 3·1-5·6), representing 45·7 million Chinese adults, and smoking, childhood pneumonia or bronchitis, parental history of respiratory disease, and low education attainment were associated with prevalent asthma.
Journal ArticleDOI
Efficacy and Safety of Low Dose Recombinant Tissue-Type Plasminogen Activator for the Treatment of Acute Pulmonary Thromboembolism: A Randomized, Multicenter, Controlled Trial
Chen Wang,Zhenguo Zhai,Yuanhua Yang,Qi Wu,Zhaozhong Cheng,Lirong Liang,Huaping Dai,Kewu Huang,Weixuan Lu,Zhonghe Zhang,Xiansheng Cheng,Ying H. Shen +11 more
TL;DR: The notion that optimizing rt-PA dosing is worthwhile when treating patients with PTE is supported, as Progressive improvements in RVDs, lung perfusion defects, and pulmonary artery obstructions were found to be similarly significant in both treatment groups.
Journal ArticleDOI
Pulmonary embolism incidence and fatality trends in chinese hospitals from 1997 to 2008: a multicenter registration study.
TL;DR: The relatively stable PE incidence and decreasing fatality trends in Chinese hospitals may be partially attributable to the implementation of the NCCPT and suggest the government should reevaluate the severity of PE so that health resources for the prevention, diagnosis and treatment of PE could be used to their fullest.
Journal ArticleDOI
Lower dosage of recombinant tissue-type plasminogen activator (rt-PA) in the treatment of acute pulmonary embolism: A systematic review and meta-analysis
TL;DR: A systematic review and meta-analysis suggested that low dose rt-PA had similar efficacy but was safer than standard dose of rT-PA, and compared with heparin, low doses didn't increase the risk of major bleeding for eligible PE patients.